Elanco Animal Health Inc (NYSE:ELAN) finished Thursday with an addition of $0.07 to close at $11.19, an upside of 0.63 percent. An average of 3,531,600 shares of common stock have been traded in the last five days. There was a fall of -$0.14 in the past week, and it reached a new high 12 times over the past 12 months. The last 20 days have seen an average of 4,508,070 shares traded, while the 50-day average volume stands at 5,230,394.
ELAN stock has decreased by -11.33% in the last month. The company shares reached their 1-month lowest point of $11.02 on 09/27/23. With the stock rallying to its 52-week high on 02/02/23, shares of the company touched a low of $7.88 and a high of $14.69 in 52 weeks. It has reached a new high 10 times so far this year and lost -8.43% or -$1.03 in price. In spite of this, the price is down -23.83% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Elanco Animal Health Inc (ELAN) stock’s beta is 1.01. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.27, the price-to-book (PB) ratio at 0.74.
Financial Health
The quick ratio of Elanco Animal Health Inc for the three months ended June 29 was 1.53, and the current ratio was 2.84, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.81 and a total debt to equity ratio of 0.82 for the quarter ending June 29. Its gross profit as reported stood at $2.5 billion compared to revenue of $4.41 billion.
Earnings Surprise
For the three-month period that ended June 29, Elanco Animal Health Inc had $6.02 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$97.0 million in the quarter, while revenues were grew 77.32%. The analyst consensus anticipated Elanco Animal Health Inc’s latest quarter earnings to come in at $0.05 per share, but it turned out to be $0.18, a 260.00% surprise. For the quarter, EBITDA amounted to $195.0 million. Shareholders own equity worth $492.68 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Elanco Animal Health Inc (ELAN) price momentum. RSI 9-day as of the close on 28 September was 36.04%, suggesting the stock is Neutral, with historical volatility in this time frame at 18.37%.
As of today, ELAN’s price is $11.24 -1.24% or -$0.14 from its 5-day moving average. ELAN is currently trading -9.76% lower than its 20-day SMA and +20.19% higher than its 100-day SMA. However, the stock’s current price level is -5.33% below the SMA50 and -11.68% below the SMA200.
The stochastic %K and %D were 17.16% and 16.82%, respectively, and the average true range (ATR) was 0.31. With the 14-day stochastic at 16.19% and the average true range at 0.33, the RSI (14) stands at 40.42%. The stock has reached -0.20 on the 9-day MACD Oscillator while the 14-day reading was at -0.35.
Analyst Ratings
Barclays upgraded Elanco Animal Health Inc (NYSE: ELAN) to a an Overweight rating in its most recent analyst report. Previously, the stock was rated as an Equal weight.
